Literature DB >> 11906454

Wild-type intracellular bacteria deliver DNA into mammalian cells.

Catherine Grillot-Courvalin1, Sylvie Goussard, Patrice Courvalin.   

Abstract

Gene transfer in vitro from intracellular bacteria to mammalian phagocytic and non-phagocytic cells and in vivo in mice has been reported. The bacteria used as DNA delivery vectors were engineered to lyze upon entry in the cell due to impaired cell wall synthesis for Shigella flexneri and invasive Escherichia coli, or production of a phage lysin for Listeria mono- cytogenes. In vivo gene transfer was obtained with attenuated Salmonella typhimurium and resulted in stimulation of mucosal immunity. We report that wild-type intracellular human pathogens, such as L. monocytogenes EGD or LO28 and S. flexneri M90T, mediate efficient in vitro transfer of functional genes into epithelial and macrophage cell lines. A low- efficiency transfer was obtained from strain EGD to mouse peritoneal macrophages. DNA transfer with S. typhimurium was observed only from atten-uated aroA strain SL7207 into COS-1 cell line. As demonstrated by the study of listeriolysin-defective L. monocytogenes or of S. typhimurium SL7207 aroA engineered to secrete listeriolysin, escape of bacteria or of plasmid DNA from the intracytoplasmic vacuole is required for transfer of genetic information to occur.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11906454     DOI: 10.1046/j.1462-5822.2002.00184.x

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  14 in total

1.  Listeria monocytogenes is sensed by the NLRP3 and AIM2 inflammasome.

Authors:  Sarah Kim; Franz Bauernfeind; Andrea Ablasser; Gunther Hartmann; Katherine A Fitzgerald; Eicke Latz; Veit Hornung
Journal:  Eur J Immunol       Date:  2010-06       Impact factor: 5.532

2.  Biomaterials at the interface of nano- and micro-scale vector-cellular interactions in genetic vaccine design.

Authors:  Charles H Jones; Anders P Hakansson; Blaine A Pfeifer
Journal:  J Mater Chem B       Date:  2014-09-12       Impact factor: 6.331

3.  Hybrid biosynthetic gene therapy vector development and dual engineering capacity.

Authors:  Charles H Jones; Anitha Ravikrishnan; Mingfu Chen; Ryan Reddinger; Mahmoud Kamal Ahmadi; Snehal Rane; Anders P Hakansson; Blaine A Pfeifer
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-11       Impact factor: 11.205

4.  Proliferation behavior of E. coli in a three-dimensional in vitro tumor model.

Authors:  Nelita Elliott; Tae Lee; Lingchong You; Fan Yuan
Journal:  Integr Biol (Camb)       Date:  2011-05-10       Impact factor: 2.192

5.  Induction of Specific CD8 T Cells against Intracellular Bacteria by CD8 T-Cell-Oriented Immunization Approaches.

Authors:  Toshi Nagata; Yukio Koide
Journal:  J Biomed Biotechnol       Date:  2010-05-24

6.  Prospects for the use of artificial chromosomes and minichromosome-like episomes in gene therapy.

Authors:  Sara Pérez-Luz; Javier Díaz-Nido
Journal:  J Biomed Biotechnol       Date:  2010-08-24

7.  Genetic alteration of Mycobacterium smegmatis to improve mycobacterium-mediated transfer of plasmid DNA into mammalian cells and DNA immunization.

Authors:  Yongkai Mo; Natalie M Quanquin; William H Vecino; Uma Devi Ranganathan; Lydia Tesfa; William Bourn; Keith M Derbyshire; Norman L Letvin; William R Jacobs; Glenn J Fennelly
Journal:  Infect Immun       Date:  2007-07-30       Impact factor: 3.441

Review 8.  Biotechnological applications of Listeria's sophisticated infection strategies.

Authors:  Sukhadeo Barbuddhe; Trinad Chakraborty
Journal:  Microb Biotechnol       Date:  2008-06-09       Impact factor: 5.813

9.  Evaluation of recombinant invasive, non-pathogenic Eschericia coli as a vaccine vector against the intracellular pathogen, Brucella.

Authors:  Jerome S Harms; Marina A Durward; Diogo M Magnani; Gary A Splitter
Journal:  J Immune Based Ther Vaccines       Date:  2009-01-06

10.  Prodrug converting enzyme gene delivery by L. monocytogenes.

Authors:  Jochen Stritzker; Sabine Pilgrim; Aladar A Szalay; Werner Goebel
Journal:  BMC Cancer       Date:  2008-04-10       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.